| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $10.2M | -39.8% |
| SG&A Expense | $9.7M | -23.6% |
| Operating Income | -$19.4M | +36.1% |
| Pre-tax Income | -$19.4M | +36.6% |
| Income Tax | $0 | — |
| Net Income | -$19.4M | +36.1% |
| EPS (Basic) | -$4.44 | -678.9% |
| EPS (Diluted) | -$4.44 | -678.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Current Assets | $27.9M | +121.7% |
| Total Assets | $32.3M | +54.1% |
| Current Liabilities | $3.2M | +2.5% |
| Total Liabilities | $4.7M | -26.9% |
| Stockholders' Equity | $27.6M | +90.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.7M | +47.4% |
| Investing Cash Flow | $0 | +100.0% |
| Financing Cash Flow | $28.6M | +101.9% |